Absolute Count of CD3+ CD4+ T Cells (Peripheral Blood)
This test measures the number of specific immune cells in your blood, which helps assess your immune system’s strength and identify potential immune-related conditions.
["A lower count may signal weakened immunity or immune disorders; a higher count may need further evaluation for overactive immune responses."]
Key facts at a glance
- LOINC
- 106910-3
- Short code
- BAL-CD4CD8
- Synonyms
- CD3+CD4+ Cells/CD3+CD8+ Cll BAL FC
- Category
- chemistry
- Sample
- serum
- Container
- Sterile BAL collection container; transfer to sterile polypropylene tube for flow cytometry. Keep at room temperature and process within 2-4 hours of collection for optimal viability.
- Units
- N/A
- Ref low
- 1.5
- Ref high
- 3.5
- Critical range
- 0.5 N/A – 4 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–99 years
- Method
- flow-cytometry
- CPT
- 86360
- SNOMED
- 444100001
- Specimen volume
- Minimum 10-20 mL of BAL fluid required for flow cytometric immunophenotyping; optimal volume 30-50 mL. Saline aliquot used for lavage should be documented.
- Stability
- Process BAL fluid within 2-4 hours of collection for best lymphocyte viability. If delayed, store at 2-8°C for up to 12 hours. Do not freeze. Viability decreases significantly after 24 hours.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
Why This Test Matters
Your immune system relies on specialized white blood cells, including T-cells, to fight infections and regulate immune responses. CD3+ CD4+ T-cells are a key subset of these cells, often measured to diagnose or monitor conditions like HIV, autoimmune diseases, or immune deficiencies.
What to Expect During Testing
A simple blood draw is used to collect a small sample. The test analyzes the count of these specific immune cells, providing insights into your immune health without requiring fasting or special preparation.
Common Conditions Monitored
This test is often used in patients with HIV/AIDS to track immune function, in those with autoimmune diseases (e.g., rheumatoid arthritis, lupus) to monitor immune activity, or in individuals with suspected immune deficiencies.
Preparation and Timing
No special preparation is needed. Results are typically available within 24–48 hours, depending on lab processing times.
Reference range
CD4/CD8 ratio in BAL fluid: 1.5 - 3.5 (ratio). Normal BAL lymphocyte population shows CD4/CD8 ratio similar to or slightly higher than peripheral blood. A ratio >3.5 suggests sarcoidosis or hypersensitivity pneumonitis; a ratio <1.0 suggests opportunistic infections or certain interstitial lung diseases.N/A
Patient should fast for at least 4-6 hours prior to bronchoscopy. Bronchoscopy typically performed under sedation; inform physician of any anticoagulant use. No specific dietary restrictions beyond standard bronchoscopy preparation. Patient should sign informed consent for bronchoscopy procedure.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: Interpretation and Next Steps
Short name
CD3/CD4 T-cell count
Frequently asked questions
What does a low CD3/CD4 count mean?
What if my count is high?
How often should I get this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy